« FDA Approves First Compact Heart Assist Device The U.S. Food | Main | FDA Approvals - Acusphere Submits New Drug Application for FDA Approval of Imagify(TM) »

FDA Approvals - Osteotech's Plexur P(TM) Receives FDA Clearance As Bone Void Filler


Osteotech's Plexur P(TM) Receives FDA Clearance As Bone Void Filler And Bone Graft Extender In Spine (Medical News Today)
Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic solutions for regenerative medicine, announced that the United States Food and Drug Administration ("FDA") has cleared its 510(k) submission for the Plexur P(TM) Biocomposite for use in spinal applications as a bone void filler and as a bone graft extender.

Akorn-Strides, LLC Announces FDA Approvals for Ondansetron Injection . USP, 4 mg/2mL Single Dose Vials and Ondansetron ... (InfoBolsa)
USP, 4 mg/2mL Single Dose Vials and Ondansetron Injection USP, 40 mg/20mL 24/04/2008 11:00:00 Business Wire US2074101013 Akorn-Strides, LLC today announced the approvals of two ANDAs for Ondansetron Injection USP, 4 mg/2mL Single Dose Vials and Ondansetron Injection USP, 40 mg/20mL Multiple Dose Vials.
 

©2006 FDA-News.com. All rights reserved.